SomaLogic founder, CTO among shareholders opposing Standard BioTools merger – BizWest bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.
Highlights That Four SomaLogic Shareholders Have Now Openly Stated Their Intention to Vote “AGAINST” the Proposed Merger with Standard BioTools
Urges Fellow Shareholders to Vote “AGAINST”.
Investment firm Tikvah Management LLC plans to oppose SomaLogic Inc.’s (Nasdaq: SLGC) planned $1 billion merger with California-based Standard BioTools Inc. (Nasdaq: LAB), making Tikvah the second major investor to stake out a position against the deal in the last week or so.
Another investor opposes Somalogic merger – BizWest bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.
Highlights Current Merger Consideration, Which Assigns No Value and No Premium to SomaLogic’s Desirable Assets, Represents a Material Discount to Company’s Cash
Reiterates Combined Entity’s.